BLA
OFIX icon

Balter Liquid Alternatives’s Orthofix Medical OFIX Stock Holding History

Balter Liquid Alternatives’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,815
Closed -$322K – 202
2017
Q3 		$322K Sell
6,815
-3,573
-34% -$168K 0.36% 97
2017
Q2 		$483K Buy
+10,388
New +$431K 0.56% 54

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Balter Liquid Alternatives's OFIX Position: Q4 2017 in Review

Balter Liquid Alternatives sold out of Orthofix Medical (OFIX) in Q4 2017, closing a stake of 6,815 shares — an estimated $322K sold.

Balter Liquid Alternatives first reported a position in OFIX in Q2 2017 and held it in 2 quarters. The position peaked at $483K in Q2 2017. 164 funds tracked by Wall St. Rank hold OFIX as of Q4 2017.

  • Balter Liquid Alternatives reported no remaining Orthofix Medical position as of Q4 2017 after selling out during the quarter.
  • Balter Liquid Alternatives sold 6,815 Orthofix Medical shares in Q4 2017, an estimated $322K.
  • Balter Liquid Alternatives first reported a position in Orthofix Medical in Q2 2017 and held it in 2 quarters.
  • Balter Liquid Alternatives's Orthofix Medical position peaked at $483K in Q2 2017.
  • 164 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2017.

Based on Balter Liquid Alternatives's 13F filing for Q4 2017, filed 7 Feb 2018.